We present the case of an HIV/HCV-coinfected patient with HIV-related pulmonary hypertension (HRPH) who experienced a good clinical and functional response to bosentan, with a subsequent switch to oral sildenafil due to increased transaminase levels. Bosentan resulted less handy in this case, probably due to both side effects and co-morbidities.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892594 | PMC |
| http://dx.doi.org/10.4081/idr.2011.e14 | DOI Listing |
Publication Analysis
Top Keywords
pulmonary hypertension
8
bosentan sildenafil
4
sildenafil treatment
4
treatment hiv-associated
4
hiv-associated pulmonary
4
hypertension case
4
case hiv/hcv-coinfected
4
hiv/hcv-coinfected patient
4
patient hiv-related
4
hiv-related pulmonary
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!